Why Axsome Therapeutics Stock Is On Fire Today
Axsome Therapeutics (NASDAQ: AXSM), a newly minted commercial-stage biopharma, is set for a strong session today. Specifically, the company's shares are up by a whopping 52% in pre-market trading Monday morning.
What's going on? Ahead of the opening bell this morning, Axsome released an 8-K filing with the Securities and Exchange Commission revealing that it has received the proposed labeling from the Food and Drug Administration (FDA) for the experimental major depressive disorder drug known as AXS-05.
Image Source: Getty Images.
Source Fool.com
